Divergent interfaces and convergent outcome in the structural basis of HIV-2 Vif antagonism of APOBEC3H

Abstract Primate lentiviruses counteract antiviral APOBEC3 (A3) cytidine deaminases through virion infectivity factor (Vif), which recruits A3 proteins to a Cullin–RING E3 ubiquitin ligase for proteasomal degradation. While HIV-1 Vif is well characterized, HIV-2 Vif remains poorly defined due to divergent sequences. Here we report a 3.08 Å cryo-EM structure of HIV-2 Vif bound to chimpanzee A3H (cpzA3H) and E3 ligase components. HIV-2 Vif adopts a conserved global fold but engages cpzA3H through a binding interface distinct from HIV-1 Vif, achieving target recognition through numerous weak contacts distributed across an extended interface. The structure reveals a direct CBFβ–cpzA3H interface absent in HIV-1 Vif-A3H complexes, establishing CBFβ as a bivalent adaptor that actively contributes to substrate recruitment. Despite these structural differences, lysine 50 of cpzA3H is the shared ubiquitination target of both HIV-1- and HIV-2 Vif-induced degradation, revealing convergent function achieved through divergent structural solutions.

Authors

Publication Details

Journal
Nature Communications
Published
2026-10-07
DOI
https://doi.org/10.1038/s41467-026-78197-2
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Divergent interfaces and convergent outcome in the structural basis of HIV-2 Vif antagonism of APOBEC3H

Mayumi Imahashi, Hiroshi Matsuo, Katarzyna A. Skorupka, Yasumasa Iwatani et al.
Nature Communications
HIV Research and Treatment
article

Divergent interfaces and convergent outcome in the structural basis of HIV-2 Vif antagonism of APOBEC3H

Mayumi Imahashi, Hiroshi Matsuo, Katarzyna A. Skorupka, Yasumasa Iwatani, Kazuhiro Matsuoka, Yoshiyuki Yokomaku
article en

Abstract

Abstract Primate lentiviruses counteract antiviral APOBEC3 (A3) cytidine deaminases through virion infectivity factor (Vif), which recruits A3 proteins to a Cullin–RING E3 ubiquitin ligase for proteasomal degradation. While HIV-1 Vif is well characterized, HIV-2 Vif remains poorly defined due to divergent sequences. Here we report a 3.08 Å cryo-EM structure of HIV-2 Vif bound to chimpanzee A3H (cpzA3H) and E3 ligase components. HIV-2 Vif adopts a conserved global fold but engages cpzA3H through a binding interface distinct from HIV-1 Vif, achieving target recognition through numerous weak contacts distributed across an extended interface. The structure reveals a direct CBFβ–cpzA3H interface absent in HIV-1 Vif-A3H complexes, establishing CBFβ as a bivalent adaptor that actively contributes to substrate recruitment. Despite these structural differences, lysine 50 of cpzA3H is the shared ubiquitination target of both HIV-1- and HIV-2 Vif-induced degradation, revealing convergent function achieved through divergent structural solutions.

Nature Communications
Openalex Percentile: Top 15%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Divergent interfaces and convergent outcome in the structural basis of HIV-2 Vif antagonism of APOBEC3H — Mayumi Imahashi, Hiroshi Matsuo, et al. · Nature Communications (2026) | TGRS Research Map | TGRS